DEF: XMAX Inc. Seeks Shareholder Approval for Capital Raise

Sentiment:

Proxy Statement


XMAX Inc. is holding a special meeting on November 2, 2026, to seek shareholder ratification of past share issuances and approval for future private and registered direct offerings to fund AI business development.

Capital raiseThe company plans to conduct a private placement offering of up to 15,000,000 shares of common stock, aiming to raise up to $85,000,000.The company also plans to conduct a registered direct offering under an effective registration statement on Form S-3, also for up to 15,000,000 shares and aiming to raise up to $85,000,000.These offerings are intended to fund new business development in AI software and hardware, cloud and GPU compute infrastructure, AI model access and orchestration, and enterprise-focused AI agent deployment.The shares in both offerings will be issued at a price lower than the Nasdaq Minimum Price, with a maximum discount of up to 50% of the closing price on the preceding trading day.

Summary

  • XMAX Inc. is convening a special meeting of stockholders on November 2, 2026, to vote on several key proposals.
  • The proposals include ratifying certain past share issuances that may have violated Nasdaq Listing Rule 5635(d) and approving two significant capital-raising initiatives: a private placement and a registered direct offering.
  • These offerings are intended to raise capital for the company's new business development strategy in high-growth AI segments.
  • The company is also seeking authority to adjourn the meeting if necessary to solicit additional proxies.
  • The record date for determining eligible voters is September 15, 2026, with 64,875,626 shares outstanding.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it addresses Nasdaq compliance issues and outlines plans for necessary capital raises to fund strategic growth, though dilution is a concern.

Positives

  • The company is proactively addressing Nasdaq compliance issues related to past share issuances.
  • The proposed capital raises are intended to fund strategic expansion into high-growth AI segments.
  • The company is seeking shareholder approval for these significant financial transactions, demonstrating a commitment to corporate governance.
  • The registered direct offering will be conducted under an effective registration statement on Form S-3, providing a regulated path for capital raising.

Negatives

  • The company has received a notification from Nasdaq for non-compliance with Listing Rule 5635(d) regarding prior shareholder approval for certain share issuances.
  • The proposed private placement and registered direct offerings involve issuing more than 20% of outstanding common stock at prices potentially below the Nasdaq Minimum Price, which will dilute existing shareholders' ownership.
  • The terms and conditions of the private placement and registered direct offerings have not yet been finalized.
  • There is a risk that the proposed plan to regain Nasdaq compliance may not be accepted by Nasdaq.

Risks

  • Failure to regain compliance with Nasdaq Listing Rule 5635(d) could jeopardize the company's listing on The Nasdaq Capital Market.
  • The issuance of new shares in the private placement and registered direct offerings will dilute the ownership percentage of existing shareholders.
  • Investors in the private placement and registered direct offerings could acquire large blocks of stock, potentially concentrating voting power.
  • There is no assurance that the proposed capital raises will be successful or that Nasdaq will accept the company's plan to regain compliance.

Future Outlook

The company plans to raise capital through a private placement and a registered direct offering to fund its expansion into AI segments. The success of these offerings and the company's ability to regain Nasdaq compliance are key to its future outlook.

Management Comments

  • The Board believes that it is in the best interest of the Company and its shareholders to approve and ratify March and April Issuances.
  • The Board determined that continued listing on The Nasdaq Capital Market is in the best interest of the Company and its shareholders, and that the shareholders approval and ratification is the best path forward to maintain the listing on The Nasdaq Capital Market.
  • If approved, we believe we will be able to quickly complete the proposed Private Placement and obtain the capital necessary to fund our business and maintain our listing on the Nasdaq Capital Market.
  • If approved, we believe we will be able to quickly complete the proposed Registered Direct Offering and obtain the capital necessary to fund our business and maintain our listing on the Nasdaq Capital Market.

Industry Context

StockSavvy.ai notes that XMAX Inc.'s focus on AI segments aligns with a broader industry trend of companies investing heavily in artificial intelligence for growth and competitive advantage. The need for capital raises, especially at potentially discounted prices, is common for companies seeking to fund ambitious R&D and infrastructure development in rapidly evolving tech sectors.

Stakeholder Impact

  • Shareholders will experience dilution in their ownership percentage due to the proposed share issuances.
  • Shareholders may see concentrated voting power if a few investors acquire large blocks of stock.
  • The company's ability to maintain its Nasdaq listing is crucial for all stakeholders.

Next Steps

  • Stockholders to vote on the four proposals at the Special Meeting on November 2, 2026.
  • The company will await Nasdaq's response to its plan of compliance.
  • If the plan is accepted, Nasdaq may grant an extension of up to 180 days to evidence compliance.
  • If the plan is not accepted, the company may request a hearing to appeal the decision.
  • Completion of the private placement and registered direct offerings, subject to shareholder approval and market conditions.

Key Dates

DateDescription
2025-12-18Net Official Closing Price (NOCP) for XMAX Inc. common stock was $6.02.
2025-12-19Company entered into a Securities Purchase Agreement to issue 1,187,500 shares of common stock at $4.21 per share (December Issuance).
2026-03-09Date of a transaction involving the issuance of 8,500,000 shares.
2026-03-30Date of a transaction involving the issuance of 1,958,000 shares.
2026-04-24Date of a transaction involving the issuance of 8,550,000 shares.
2026-05-12Effective date of the Registration Statement on Form S-3 (Registration Number 333-295406).
2026-09-10Nasdaq Stock Market LLC issued a notification letter regarding non-compliance with Listing Rule 5635(d).
2026-09-15Record date for determining stockholders entitled to vote at the Special Meeting.
2026-09-30Company provided a plan of compliance to Nasdaq.
2026-10-05Date of the Proxy Statement and Notice of Special Meeting.
2026-10-06Proxy statement and proxy card are being mailed to stockholders of record.
2026-10-26Deadline for the Company to submit a plan to regain compliance with Nasdaq Listing Rule 5635(d).
2026-11-01Deadline for telephone and Internet voting.
2026-11-02Date of the Special Meeting of Stockholders.

Recommendation

hold

The filing indicates a need for capital to fund strategic growth in AI, which is positive. However, the Nasdaq compliance issues, potential dilution from significant share issuances at a discount, and the uncertainty of Nasdaq's decision warrant a cautious 'hold' stance until more clarity emerges on these fronts.

Keywords

XMAX Inc., Special Meeting, Proxy Statement, Shareholder Approval, Nasdaq Compliance, Private Placement, Registered Direct Offering, AI

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.